Clinical impact of methicillin-resistant Staphylococcus aureus bacteremia based on propensity scores

Infection

Volumn 39, Issue 2, 2011, Pages 141-147

  Park, S Y ^a   Son, J S ^a   Oh, I H ^a   Choi, J M ^a   Lee, M S ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Hospital costs; Korea; Methicillin resistant Staphylococcus aureus; Mortality; Propensity scores

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HOSPITAL COST; HUMAN; INFECTION CONTROL; KOREA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; OUTCOME ASSESSMENT; PROPENSITY SCORE;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CASE-CONTROL STUDIES; FEMALE; HEALTH CARE COSTS; HOSPITALS; HUMANS; KOREA; LENGTH OF STAY; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PROPENSITY SCORE; STAPHYLOCOCCAL INFECTIONS;

EID: 79955574287     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-011-0100-1     Document Type: Article

References (29)

1. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley MM; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352:1436-44.
2. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470-85
3. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK; Active Bacterial Core surveillance (ABCs) MRSA Investigators. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298:1763-71.
4. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279:593-8. (Pubitemid 28110205)
5. Kim KM, Yoo JH, Choi JH, Park ES, Kim KS. The nationwide surveillance results of nosocomial infections along with antimicrobial resistance in intensive care units of sixteen university hospitals in Korea, 2004. Korean J Nosocomial Infect Control. 2006;11:79-86.
6. Haley RW, White JW, Culver DH, Hughes JM. The financial incentive for hospitals to prevent nosocomial infections under the prospective payment system. An empirical determination from a nationally representative sample. JAMA. 1987;257:1611-4.
7. Stone PW, Larson E, Kawar LN. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990-2000. Am J Infect Control. 2002;30:145-52.
8. Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med. 1998;158:182-9. (Pubitemid 28049512)
9. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol. 1999;150:327-33. (Pubitemid 29383480)
10. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128-40.
11. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1-45.
12. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing. Wayne: NCCLS; 2002.
13. McCabe WR, Jackson GG. Gram-negative bacteremia. Arch Intern Med. 1962;110:847-55.
14. Park YJ, Jeong JS, Park ES, Shin ES, Kim SH, Lee YS. Survey on the infection control of multidrug-resistant microorganisms in general hospitals in Korea. Korean J Nosocomial Infect Control. 2007;12:112-21.
15. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-55.
16. Parsons LS. Reducing bias in a propensity score matched-pair sample using Greedy matching techniques. In: Proceedings of the 26th Annual SAS Users Group International Conference, Long Beach, California, 22-25 April 2001. Cary: SAS Institute; 2001
17. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005;26:166-74. (Pubitemid 40445022)
18. Lodise TP, McKinnon PS. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis. 2005;52:113-22. (Pubitemid 40826937)
19. Reed SD, Friedman JY, Engemann JJ, Griffiths RI, Anstrom KJ, Kaye KS, Stryjewski ME, Szczech LA, Reller LB, Corey GR, Schulman KA, Fowler VG Jr. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 2005;26:175-83. (Pubitemid 40445023)
20. Lee H, Lee H, Lee K-H, Wan TTH. Comparing efficiency between public and private hospitals in South Korea. Int J Public Policy. 2008;3:430-42.
21. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36:53-9. (Pubitemid 36099097)
22. Whitby M, McLaws ML, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust. 2001;175:264-7. (Pubitemid 32851061)
23. Mylotte JM, Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis. 2000;31:1170-4. (Pubitemid 32295446)
24. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis. 2003;36:1418-23. (Pubitemid 36702876)
25. Kim SH, Park WB, Lee KD, Kang CI, Bang JW, Kim HB, Kim EC, Oh MD, Choe KW. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2004;54:489-97.
26. Melzer M, Eykyn SJ, Gransden WR, Chinn S. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis. 2003;37:1453-60. (Pubitemid 37494672)
27. Soriano A, Martínez JA, Mensa J, Marco F, Almela M, Moreno-Martínez A, Sánchez F, Muñoz I, Jiménez de Anta MT, Soriano E. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis. 2000;30:368-73. (Pubitemid 30131548)
28. Rojas EG, Liu LZ. Annual cost for the treatment of patients hospitalized with methicillin-resistant Staphylococcus aureus in the United States. Value Health. 2005;8:308.
29. Hansen S, Schwab F, Asensio A, Carsauw H, Heczko P, Klavs I, Lyytikäinen O, Palomar M, Riesenfeld-Orn I, Savey A, Szilagyi E, Valinteliene R, Fabry J, Gastmeier P. Methicillin-resistant Staphylococcus aureus (MRSA) in Europe: which infection control measures are taken? Infection. 2010;38:159-64.